RABEPRAZOLE SODIUM (RABEPRAZOLE SODIUM) — FDA Approval ANDA208644 (ALKEM LABS LTD)
RABEPRAZOLE SODIUM (RABEPRAZOLE SODIUM) — FDA Approval ANDA208644 (ALKEM LABS LTD) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: RABEPRAZOLE SODIUM; Active ingredients: RABEPRAZOLE SODIUM; Application number: ANDA208644.
| Brand name | RABEPRAZOLE SODIUM |
|---|---|
| Active ingredients | RABEPRAZOLE SODIUM |
| Application number | ANDA208644 |
| Sponsor | ALKEM LABS LTD |
| Dosage form | TABLET, DELAYED RELEASE |
| Route | ORAL |
| Marketing status | Prescription |
| Products in application | 1 |
| First approval date | 20180424 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →